Comments
The board of DIL on Thursday approved a scheme of amalgamation with its subsidiary Fermenta Biotech, a manufacturer/marketer of bulk drugs including Vitamin D3 and enzymes. Under the terms, 100 equity shares of DIL of ₹10 each would be issued for every 1,006 equity shares of FBL. As the board on June 18 recommended a stock split (to ₹5) and 1:1 bonus, FBL shareholders would receive 100 DIL shares for every 251 shares held in FBL.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.